Accelerating Radiopharmaceutical Innovation
BAMF Health is transforming personalized medicine through radiopharmaceuticals, enabling earlier detection, more accurate diagnosis, and targeted treatment for diseases like cancer, Alzheimer’s, and beyond.
To bring this vision to life, we created BAMF RadioNexus: the first-of-its-kind clinical trials network dedicated exclusively to radiopharmaceutical research.
What is BAMF RadioNexus?
BAMF RadioNexus is a specialized clinical trials platform dedicated to radiopharmaceutical innovation. We partner with pharmaceutical sponsors and health systems to overcome the operational, regulatory, and logistical complexities that often slow these critical studies down.
Whether you’re advancing targeted radiopharmaceuticals or expanding your site’s capacity for theranostic research, RadioNexus helps you build infrastructure, grow expertise, and access the support needed to initiate and complete complex trials faster and with confidence.
Why Partner with BAMF RadioNexus?
For Pharmaceutical Sponsors
- Faster, more reliable study startup and execution
- Access to diverse patient populations
- Consistent trial workflows and high-quality data capture
- Experienced, high-performing partners
For Clinical Sites and Health Systems
- Tailored onboarding and training
- Best practices in regulatory navigation and operational readiness
- Priority access to cutting-edge trials
- Grow research capabilities and patient care offerings
Our Process
We analyze your site’s current clinical research capabilities and develop a customized roadmap for launching and scaling clinical trials across single or multi-location systems.
We equip your site with operational infrastructure, including scheduling workflows, imaging and data capture processes, radiation safety tools, budgeting templates, team training, and more.
We assist with site qualification and feasibility, regulatory submissions and IRB support, development of protocol-specific workflows, and site onboarding.
We identify and act on opportunities to improve enrollment, reduce protocol deviations, increase cross-site coordination, and drive operational efficiencies.
Ready to Shape the Future of Personalized Care?
Email our team at: radionexus@bamfhealth.com
BAMF Health is working every day to conduct additional clinical trials to improve disease management using molecular imaging and molecularly targeted radiation therapy.
Clinical Trial General Interest Copy link
If you are interested in learning more about participating in a clinical trial, please fill out this form.
BAMF Health Clinical Trial Articles
Henry Ford Health and BAMF Health Break Ground on Comprehensive Theranostics Center in Downtown Detroit
BAMF Health and Henry Ford Health officially broke ground on a 45,000-square-foot facility.
April 14, 2026
World Traveler Becomes First-in-World Patient
Bill was the first patient in the world to participate in a clinical trial exploring an experimental radiopharmaceutical therapy for prostate cancer.
January 26, 2026
BAMF Health Doses First Patient in Promising New Prostate Cancer Alpha Radioligand Therapy Clinical Trial
BAMF Health dosed the first patient enrolled in a Phase 1 prostate cancer therapy clinical trial sponsored by ARTBIO.
November 25, 2025